Literature DB >> 18823437

Dietary trans-resveratrol bioavailability and effect on CCl4-induced liver lipid peroxidation.

Paola Vitaglione1, Barbara Ottanelli, Stefano Milani, Filomena Morisco, Nicola Caporaso, Vincenzo Fogliano.   

Abstract

BACKGROUND AND AIM: Several in vitro studies have demonstrated the ability of pure trans-resveratrol (t-Res) to act as an anti-oxidant, but the scientific literature is lacking in in vivo studies dealing with dietary t-Res bioavailability in oxidative stress models. Our aim was to investigate the bioavailability of t-Res from dietary sources and its effect on an animal model of carbon tetrachloride (CCl4)-induced liver lipid peroxidation.
METHODS: Ten rats were intragastrically administered for 14 days with a grape-stalk extract determining a daily t-Res dosage of 3 mg/kg. The control group (10 rats) was daily injected with the vehicle solvent without the t-Res extract. After 1 week, the induction of liver lipid peroxidation by CCl4 injection was carried out. Serum and liver samples, at different time intervals, were collected to evaluate t-Res content, by high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectometry-mass spectometry (LC-MS-MS). Liver malondialdehyde (MDA) as marker of oxidative stress was measured.
RESULTS: t-Res accumulates in the liver reaching 49.8 +/- 10.2 ng/g after 7 days and 191.8 +/- 15.3 ng/g after 14 days. No t-Res was detected in serum. The increase of MDA liver concentration due to CCl4 injection after 24 h and 1 week was reduced by 38% and a 63%, respectively, by the treatment with the t-Res extract.
CONCLUSIONS: A moderate consumption of t-Res from a dietary source resulted in a time-dose-dependent liver accumulation. It was able to counteract in vivo CCl4-induced liver lipid peroxidation thus demonstrating the hepatoprotective property of t-Res.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823437     DOI: 10.1111/j.1440-1746.2008.05598.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  11 in total

1.  Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats.

Authors:  Manar Hamed Arafa; Nanies Sameeh Mohammad; Hebatallah Husseini Atteia; Hesham Radwan Abd-Elaziz
Journal:  J Physiol Biochem       Date:  2014-06-18       Impact factor: 4.158

Review 2.  The biological responses to resveratrol and other polyphenols from alcoholic beverages.

Authors:  Lindsay Brown; Paul A Kroon; Dipak K Das; Samarjit Das; Arpad Tosaki; Vincent Chan; Manfred V Singer; Peter Feick
Journal:  Alcohol Clin Exp Res       Date:  2009-06-10       Impact factor: 3.455

Review 3.  Bioavailability of the polyphenols: status and controversies.

Authors:  Massimo D'Archivio; Carmelina Filesi; Rosaria Varì; Beatrice Scazzocchio; Roberta Masella
Journal:  Int J Mol Sci       Date:  2010-03-31       Impact factor: 5.923

Review 4.  Critical review of resveratrol in xenobiotic-induced hepatotoxicity.

Authors:  Mitchell R McGill; Kuo Du; James L Weemhoff; Hartmut Jaeschke
Journal:  Food Chem Toxicol       Date:  2015-11-10       Impact factor: 6.023

5.  Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice.

Authors:  Claudia Mitchell; Marie-Anne Robin; Alicia Mayeuf; Meriem Mahrouf-Yorgov; Abdellah Mansouri; Marie Hamard; Dominique Couton; Bernard Fromenty; Hélène Gilgenkrantz
Journal:  Am J Pathol       Date:  2009-10-01       Impact factor: 4.307

6.  The Protective Effect of Resveratrol on Concanavalin-A-Induced Acute Hepatic Injury in Mice.

Authors:  Yingqun Zhou; Kan Chen; Lei He; Yujing Xia; Weiqi Dai; Fan Wang; Jingjing Li; Sainan Li; Tong Liu; Yuanyuan Zheng; Jianrong Wang; Wenxia Lu; Qin Yin; Yuqing Zhou; Jie Lu; Hongfei Teng; Chuanyong Guo
Journal:  Gastroenterol Res Pract       Date:  2015-05-24       Impact factor: 2.260

7.  Resveratrol attenuates metabolic, sperm, and testicular changes in adult Wistar rats fed a diet rich in lipids and simple carbohydrates.

Authors:  Fabiana A de Oliveira; Waldemar S Costa; Francisco J B Sampaio; Bianca M Gregorio
Journal:  Asian J Androl       Date:  2019 Mar-Apr       Impact factor: 3.285

8.  Comparison of malondialdehyde levels and superoxide dismutase activity in resveratrol and resveratrol/donepezil combination treatment groups in Alzheimer's disease induced rat model.

Authors:  Y Lakshmisha Rao; B Ganaraja; Aradhana Marathe; Poornima A Manjrekar; Teresa Joy; Sheetal Ullal; Mangala M Pai; B V Murlimanju
Journal:  3 Biotech       Date:  2021-06-13       Impact factor: 2.406

9.  Different effects of resveratrol on dose-related Doxorubicin-induced heart and liver toxicity.

Authors:  Jaroslaw Dudka; Renata Gieroba; Agnieszka Korga; Franciszek Burdan; Wlodzimierz Matysiak; Barbara Jodlowska-Jedrych; Slawomir Mandziuk; Elzbieta Korobowicz; Marek Murias
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-26       Impact factor: 2.629

Review 10.  Resveratrol and liver: A systematic review.

Authors:  Forouzan Faghihzadeh; Azita Hekmatdoost; Payman Adibi
Journal:  J Res Med Sci       Date:  2015-08       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.